Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Irish

Endo-Agreement

More Like This

PR Newswire associated0

Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics

PR Newswire associated0

Endo Announces Divestiture of International Pharmaceuticals Business

PR Newswire associated0

Endo Completes International Pharmaceuticals Business Divestiture

Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting

PR Newswire associated0

Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa

Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

Indero Celebrates 25 Years and Looks to the Future of Clinical Research

PR Newswire associated0

Endo's Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada